0001104659-21-020783.txt : 20210211
0001104659-21-020783.hdr.sgml : 20210211
20210211170109
ACCESSION NUMBER: 0001104659-21-020783
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210211
FILED AS OF DATE: 20210211
DATE AS OF CHANGE: 20210211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40030
FILM NUMBER: 21620655
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER NAME:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Decibel Therapeutics, Inc.
CENTRAL INDEX KEY: 0001656536
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 464198709
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1325 BOYLSTON STREET
STREET 2: SUITE 500
CITY: BOSTON
STATE: MA
ZIP: 02215
BUSINESS PHONE: 617-370-8701
MAIL ADDRESS:
STREET 1: 1325 BOYLSTON STREET
STREET 2: SUITE 500
CITY: BOSTON
STATE: MA
ZIP: 02215
3
1
tm216035-1_3seq1.xml
OWNERSHIP DOCUMENT
X0206
3
2021-02-11
0
0001656536
Decibel Therapeutics, Inc.
DBTX
0000872589
REGENERON PHARMACEUTICALS, INC.
REGENERON PHARMACEUTICALS, INC.
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
0
1
0
Series B Preferred Stock
Common Stock
989299
D
Series C Preferred Stock
Common Stock
1108015
D
The Series B Preferred Stock and Series C Preferred Stock are convertible into shares of common stock of Decibel Therapeutics, Inc. ("Decibel") at any time pursuant to the terms of Decibel's Fourth Amended and Restated Certificate of Incorporation, as amended. The Series B Preferred Stock and the Series C Preferred Stock have no expiration date.
The Series B Preferred Stock and the Series C Preferred Stock are convertible into shares of common stock of Decibel on an approximately one-for-0.079 basis, with any resulting fractional shares of common stock being rounded down to the nearest whole number. The reported number of shares of underlying common stock and the conversion ratio give effect to Decibel's one-for-5.3 reverse stock split, which became effective on February 5, 2021.
/s/ Richard Gluckselig, Executive Director, Assistant General Counsel and Assistant Secretary
2021-02-11